40 Units of Tirzepatide: How Many mg Does That Equal?

You've seen a syringe scale or a compounding label, here's why 40 units comes up

Picture this: you're researching tirzepatide online and land on a forum, a social-media group, or a supplier outside the UK. Instead of doses in milligrams, everything is described in units drawn into an insulin syringe. It's confusing, and it's worth understanding why that framing exists and where it doesn't belong.

The 0.25 mg-per-unit figure comes from how some compounding pharmacies prepare tirzepatide: dissolved in a carrier solution at a concentration where each insulin-syringe unit delivers 0.25 mg of the active drug. On that scale, 40 units of tirzepatide is how many mg? Exactly 10 mg. If you're working backwards from the starting point, understanding how many units make up 2.5 mg of tirzepatide shows how the same conversion logic applies at the lowest end of the titration schedule. The arithmetic is clean and consistent across that concentration, but it only holds if the solution was made at that exact concentration, which is precisely the problem with unlicensed preparations.

Licensed Mounjaro pens (the ones dispensed through a UK pharmacy like ours) eliminate this entirely. The pen is pre-set. There is no syringe, no drawing up, no unit counting. You select your dose in milligrams on the dial, inject, and that's it. The risk of a concentration error, a calculation mistake, or a contaminated preparation does not exist in the same way when you use a factory-sealed, MHRA-regulated pen from the licensed supply chain.

If you have a pen in front of you and are trying to decode whether 40 units matches your prescribed dose, the short answer is: for licensed Mounjaro KwikPens, that question doesn't arise. Your dose is printed on the pen itself, in milligrams.

Where 10 mg sits in the Mounjaro schedule, and why reaching it takes time

Knowing that 40 units of tirzepatide equals 10 mg is only useful if you also know what 10 mg means clinically. It is the fourth of six strengths in the licensed UK titration pathway: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg.

Treatment begins at 2.5 mg. That starting dose exists to give your digestive system time to adjust, nausea, constipation and a slowed stomach are common early on, and the gradual step-up minimises how sharply they hit. Most people move up every four weeks, guided by their prescriber. Arriving at 10 mg, then, typically happens after around three months on treatment, not at the start.

For a closer look at how earlier doses translate across the same unit scale, 30 units of tirzepatide equals 7.5 mg, the step just below 10 mg, useful if you are tracking your titration progress. If you've been curious about the middle of the titration journey, how many units make up 5 mg of tirzepatide is a helpful reference for understanding where that dose sits on the same syringe scale. The 5 mg step is usually the first meaningful therapeutic dose after the initial starter period.

The NHS tirzepatide page is a reliable reference for the licensed UK schedule and what side effects to watch for at each stage. What a prescriber will not do is let you jump straight to 10 mg on day one, regardless of what the unit maths says your target dose works out to. The titration pacing is there for a reason, and shortcuts around it tend to make the early side-effect window harder, not easier.

The safety case for licensed, pre-filled pens over unit-based preparations

This might feel like an obvious point, but it's worth making plainly: units language in tirzepatide discussions is almost always a signal that someone is dealing with a compounded or unlicensed preparation. That matters.

The MHRA has issued repeated warnings about fake and illegally traded weight-loss medicines sold online. In late 2025, enforcement action uncovered approximately 20 million doses of illegally traded products with a street value around £45 million, including the first UK site manufacturing counterfeit tirzepatide pens. A preparation labelled in units gives you no guarantee of actual concentration, sterility, or even which active ingredient is inside. The MHRA's Yellow Card scheme exists partly to capture harm reports from exactly these situations.

Licensed Mounjaro pens from a GPhC-registered pharmacy carry a fixed, pre-verified dose with no calculation required on your part. That is not a small convenience, it is a meaningful safety margin. If you're researching costs alongside all of this, our Mounjaro pricing page sets out what a legitimate private prescription involves and why the cheapest listing is rarely the right question to ask for a prescription medicine.

What to do if you're already on tirzepatide and have a question about your dose

A genuine feeling many people share at this point in their research: you've worked out the maths, you understand the schedule, and you still feel uncertain. That's entirely reasonable. Dose questions (whether you're on the right strength, whether it's time to move up, whether a missed pen changes anything) belong with your prescriber, not a conversion table.

At nume, a real prescriber reviews every consultation and every repeat order before anything is dispensed. No algorithm makes that call. If a dose question comes up between orders, our aftercare team is available seven days a week. You can reach us through our contact page any time, or explore our FAQs for answers to the questions our prescribers hear most often.

If you're still weighing up whether tirzepatide is right for your situation, our treatment overview covers the full picture. And if you're ready to find out whether you're clinically suitable, start your free consultation with our clinical team today.